[1]
Y. . Watcharananan and S. . Kurathong, “Effects of dapagliflozin on vascular calcification among patients with chronic kidney disease without diabetes: a randomized controlled trial”, J Nephrol Soc Thail, vol. 27, no. 2, pp. 57–68, Jan. 2022.